- Phone
-
Address
1355 Greenland Avenue, Suzhou City, Jiangsu Province
Suzhou Qianshe Biotechnology Co., Ltd
1355 Greenland Avenue, Suzhou City, Jiangsu Province
Cell name:Human colorectal adenocarcinoma cell line resistant to cisplatinHCT15/DDP
Item No.WS155((HCT15)STR 鉴定)
Specifications1 × 10 ⁶ cells/T25 culture bottle
Purpose: For scientific research purposes only

1、 Cell Introduction
The cell isA DDP resistant cell line constructed from HCT15 cells.
2、 Cell characteristics
1) Source: Rectal cancer
2) Morphology: Epithelial like, adherent growth
3) Content:>1x106 cell count
4) Specification: Packaging in T25 bottles or 1mL cryovials
5) Purpose: For scientific research purposes only.
3、 Preparation of culture medium and culture cryopreservation conditions
1)Please refer to the instruction manual for details.
We recommend serum FBS500-WP-002
2) Cultivation conditions: Gas phase: air, 95%; Carbon dioxide, 5%. Temperature: 37 degrees Celsius, humidity in the incubator is 70% -80%.
3) Cryovial solution: 90% serum, 10% DMSO, ready to use and prepare.
4cell processing
1) Recovery of frozen cells
Will containThe frozen tube containing 1mL cell suspension was rapidly shaken and thawed in a 37 ℃ water bath, and then added to a centrifuge tube containing 4-6mL of culture medium and mixed evenly. Centrifuge at 1000RPM for 3-5 minutes, discard the supernatant and culture mediumResurrected cells. Then add the cell suspension to a culture bottle (or dish) containing 6-8ml of culture medium and culture overnight at 37 ℃. The next day, observe cell growth and cell density under a microscope.
2) Cell passage: If the cell density reaches 80% -90%, passage culture can be carried out.
For the passage of adherent cells, the following methods can be referred to
1. Discard the culture supernatant and rinse the cells 1-2 times with PBS that does not contain calcium or magnesium ions.
2. Add 0.25% (w/v) pancreatic white enzyme-0.53 mM EDTA to culture bottles (T25 bottle 1-2mL, T75 bottle 2-3mL), place in a 37 ℃ incubator for digestion for 1-2 minutes (difficult to digest cells can extend the digestion time appropriately), and then observe the cell digestion under a microscope. If most of the cells become round and fall off, quickly take them back to the operating table, tap the culture bottle a few times, and add 3-4ml of culture medium containing 10% FBS to terminate digestion.
3. Gently mix and aspirate, centrifuge at 1000RPM for 3-5 minutes, discard the supernatant, add 1-2mL of culture medium and blow evenly. Divide the cell suspension into new T25 bottles in a ratio of 1:2, add 6-8ml of new culture medium prepared according to the instructions to maintain the growth vitality of the cells, and proceed with subsequent passages in a ratio of 1:2 to 1:5 based on the actual situation.
Attention: Cell passageIf proliferation can still be maintained after 1-2 cycles, the drug concentration can be increased to 0.5ug/mL for further cultivation; If the cell proliferation stops during this process and the condition is poor, the drug concentration needs to be reduced (by half) or cultured in a medium without drugs until the cell density is about 8 × 105 cells/mL and the growth condition is good, then the required drug concentration should be replaced.
3) Cell cryopreservation: It is recommended to freeze a batch of cell seeds during the first 3 generations of culture after receiving the cells for subsequent experimental use.
belowTaking T25 bottle as an example;
1. When freezing cells, collect digested cells into centrifuge tubes according to the process of cell passage, and use a hemocytometer to determine the freezing density of cells. The recommended freezing density for general cells is 1 × 106~1 × 107 live cells/ml
Centrifuge at 1000rpm for 3-5 minutes and remove the supernatant. Resuspend the cells in the prepared cell cryopreservation solution, and distribute them into a cryopreservation tube at a concentration of 1 × 106~1 × 107 live cells/ml per 1ml of cryopreservation solution. Label the cells with their names, generations, dates, and other information.
Attention: Do not add drugs during cell cryopreservation.
2. Place the cells to be frozen in a programmed cooling box, refrigerate at -80 degrees Celsius overnight, and then transfer them to a liquid nitrogen container for storage. Simultaneously record the position of the cryovial in the liquid nitrogen container for future reference and use.
Human colorectal adenocarcinoma cell line HCT15/DDP resistant to cisplatin
| Human acute T lymphoblastic leukemia cells carrying luciferase | Jurkat+LUC |
| Human lung cancer cells carrying luciferase | A549+LUC |
| Human colon cancer cells carrying luciferase | HCT-116+LUC |
| Human pancreatic cancer cell luciferase | AsPC-1+LUC |
| Human liver cancer cells carrying luciferase | HuH-7+LUC |
| Human breast cancer cells with red fluorescence | MDA-MB-468+RFP |
| Human malignant glioma cells carrying luciferase | U87MG+LUC |
| Human breast cancer cells with luciferase | MDA-MB-231+LUC |
| Human gastric cancer cell luciferase labeling | NCI-N87+LUC |
| Human multiple myeloma cells carrying luciferase | MM.1S+LUC |
| Immortalization+GFP of human breast cancer fibroblasts | |
| Fluorescent enzyme labeling of human cervical cancer cells | Hela+LUC |
| Human osteosarcoma cells carrying luciferase | 143B+LUC |
| HUVEC+RFP human umbilical vein endothelial cell immortalization+RFP | HUVEC+RFP |
| Human prostate cancer cells with luciferase PC-3+LUC | PC-3-LUC |
| Human invasive choroidal melanoma cell line MUM2B-LUC | MUM2B-LUC |
| Red fluorescence of mouse lung cancer cells | LLC+RFP |
| Mouse osteosarcoma osteoblasts carrying luciferase | K7M2wt/LUC |
| Mouse acute myeloid leukemia - green+luciferase labeling | C1498-GFP+LUC |
| Green Label for Acute Myeloid Leukemia in Mice | C1498-GFP |
| Transfection of mouse melanoma cells | B16-F10+OVA |
| Transfection of mouse breast cancer cells | 4T1+OVA |
| Red fluorescence of mouse embryonic fibroblasts | NIH/3T3/RFP |
| Mouse liver cancer cells carrying luciferase | Hepa1-6+LUC |
| Mouse colon cancer cells carrying luciferase | CT26.WT/LUC |
| Mouse glioblastoma strain with luciferase | G422+LUC |
| Mouse bladder cancer cells with luciferase | MB49+LUC |
| Mouse acute myeloid leukemia with luciferase | C1498+LUC |
| Mouse monocyte macrophage leukemia cells labeled with green fluorescence RAW264.7+GFP | RAW264.7+GFP |
| Mouse glioma cells carrying luciferase | GL261+LUC |
| Mouse breast cancer cells with luciferase | 4T1+LUC |
| Mouse lung cancer cells carrying luciferase | LLC+LUC |
| Mouse lung cancer cells with green fluorescence | LLC+GFP |
| Mouse gastric cancer cells carrying luciferase | MFC+LUC |
| Mouse monocyte macrophage leukemia cells carrying luciferase | RAW264.7+LUC |